135 related articles for article (PubMed ID: 37712442)
1. Thymocyte selection-associated high mobility box protein regulates T lymphocytes exhaustion in patients with myelodysplastic syndromes by inhibiting PI3K/AKT/mTOR pathway.
Niu H; Zhang M; Liu M; Yang L; Yang L; Ren J; Yu Y; Liu Y; Xing L; Shao Z; Wang H
Hematol Oncol; 2024 Jan; 42(1):e3224. PubMed ID: 37712442
[TBL] [Abstract][Full Text] [Related]
2. Role, function and regulation of the thymocyte selection-associated high mobility group box protein in CD8
Cheng Y; Shao Z; Chen L; Zheng Q; Zhang Q; Ding W; Zhang M; Yu Q; Gao D
Immunol Lett; 2021 Jan; 229():1-7. PubMed ID: 33186634
[TBL] [Abstract][Full Text] [Related]
3. CD8
Tao J; Han D; Gao S; Zhang W; Yu H; Liu P; Fu R; Li L; Shao Z
J Cell Mol Med; 2020 Jan; 24(1):1046-1058. PubMed ID: 31756785
[TBL] [Abstract][Full Text] [Related]
4. TOX promotes the exhaustion of antitumor CD8
Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
[TBL] [Abstract][Full Text] [Related]
5. High TOX expression on CD8
Niu H; Yan L; Yang L; Zhang M; Liu M; Ren J; Shao Z; Fu R; Xing L; Wang H
Ann Hematol; 2023 May; 102(5):1247-1255. PubMed ID: 36933041
[TBL] [Abstract][Full Text] [Related]
6. PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway.
Zhao R; Song Y; Wang Y; Huang Y; Li Z; Cui Y; Yi M; Xia L; Zhuang W; Wu X; Zhou Y
Cell Prolif; 2019 May; 52(3):e12571. PubMed ID: 30714229
[TBL] [Abstract][Full Text] [Related]
7. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
8. [The expression and correlation analysis of TOX and inhibitory receptors on peripheral blood CD8
Yan L; Yang JR; Wang HQ; Shao ZH
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2095-2099. PubMed ID: 37455127
[No Abstract] [Full Text] [Related]
9. TOX is expressed by exhausted and polyfunctional human effector memory CD8
Sekine T; Perez-Potti A; Nguyen S; Gorin JB; Wu VH; Gostick E; Llewellyn-Lacey S; Hammer Q; Falck-Jones S; Vangeti S; Yu M; Smed-Sörensen A; Gaballa A; Uhlin M; Sandberg JK; Brander C; Nowak P; Goepfert PA; Price DA; Betts MR; Buggert M
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32620560
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Pattern Analysis of Virus-Specific CD8+ T Cells in Hepatitis C Infection: Increased Expression of TOX and Eomesodermin During and After Persistent Antigen Recognition.
Wildner NH; Walker A; Brauneck F; Ditt V; Peine S; Huber S; Haag F; Beisel C; Timm J; Schulze Zur Wiesch J
Front Immunol; 2022; 13():886646. PubMed ID: 35734162
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis.
Yao X; Yan C; Zhang L; Li Y; Wan Q
Medicine (Baltimore); 2018 Apr; 97(16):e0473. PubMed ID: 29668625
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromes.
Dong X; Han Y; Liu Y; Yang L; Niu H; Yan L; Liu C; Shao Z; Xing L; Wang H
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e119-e128. PubMed ID: 34152084
[TBL] [Abstract][Full Text] [Related]
14. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract][Full Text] [Related]
15. TOX-expressing terminally exhausted tumor-infiltrating CD8
Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome data-based status of PI3K/AKT/mTOR pathway indicates heterogeneity and immune modulation in patients with pancreatic ductal adenocarcinoma.
Xie P; Tan SY; Li HF; Tang HD; Zhou JH
J Gene Med; 2024 Jan; 26(1):e3570. PubMed ID: 37482968
[TBL] [Abstract][Full Text] [Related]
17. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
[TBL] [Abstract][Full Text] [Related]
18. S100a9 deficiency accelerates MDS-associated tumor escape via PD-1/PD-L1 overexpression.
Wang R; Zhao Y; Li Z; Guo J; Zhao S; Song L; Wu D; Wang L; Chang C
Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(2):194-201. PubMed ID: 36810783
[TBL] [Abstract][Full Text] [Related]
19. FAM83H overexpression predicts worse prognosis and correlates with less CD8
Zhuang H; Zhang C; Hou B
Clin Transl Oncol; 2020 Dec; 22(12):2244-2252. PubMed ID: 32424701
[TBL] [Abstract][Full Text] [Related]
20. IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model.
Lutz V; Hellmund VM; Picard FSR; Raifer H; Ruckenbrod T; Klein M; Bopp T; Savai R; Duewell P; Keber CU; Weigert A; Chung HR; Buchholz M; Menke A; Gress TM; Huber M; Bauer C
Cancer Immunol Res; 2023 Apr; 11(4):421-434. PubMed ID: 36758176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
